International Journal on Science and Technology
E-ISSN: 2229-7677
•
Impact Factor: 9.88
A Widely Indexed Open Access Peer Reviewed Multidisciplinary Bi-monthly Scholarly International Journal
Home
Research Paper
Submit Research Paper
Publication Guidelines
Publication Charges
Upload Documents
Track Status / Pay Fees / Download Publication Certi.
Editors & Reviewers
View All
Join as a Reviewer
Get Membership Certificate
Current Issue
Publication Archive
Conference
Publishing Conf. with IJSAT
Upcoming Conference(s) ↓
Conferences Published ↓
ALSDAHW-2025
Contact Us
Plagiarism is checked by the leading plagiarism checker
Call for Paper
Volume 17 Issue 2
April-June 2026
Indexing Partners
COVID-19 Sequelae in Recovered Patients A Comprehensive Narrative Review of Post-Acute Effects, Organ Involvement, and Clinical Management
| Author(s) | Dr. Hridesh Singh Patel |
|---|---|
| Country | India |
| Abstract | COVID-19 recovery is not always complete at the end of the acute infection. A substantial subset of survivors develops persistent or relapsing symptoms, sometimes termed long COVID or post-COVID-19 condition. This narrative review synthesizes current evidence on the major sequelae seen in recovered patients, with emphasis on respiratory, cardiovascular, neurological, neuropsychiatric, and pediatric manifestations. Contemporary public-health guidance defines long COVID as a chronic condition that appears after SARS-CoV-2 infection and can last for months or years, with no single diagnostic test and no universally curative therapy. Across large systematic reviews, the most common persistent symptoms include fatigue, dyspnea, cognitive dysfunction, anxiety, depression, and sleep disturbance, while organ-specific outcomes include myocardial injury, dysautonomia, interstitial lung disease, reduced exercise tolerance, and post exertional symptom worsening. Mechanistic models increasingly support a multifactorial syndrome involving viral persistence, immune dysregulation, endothelial injury, autonomic dysfunction, microvascular abnormalities, and altered gut-brain signaling. Evidence-based management remains symptom-directed and multidisciplinary, combining rehabilitation, mental health support, careful assessment for alternative diagnoses, and risk reduction through vaccination and prevention of severe acute disease. The review concludes that the sequelae of COVID-19 represent a major long-term public-health burden and that future progress depends on standardized definitions, biomarkers, phenotype-driven care pathways, and trials of targeted therapies. |
| Keywords | COVID-19, long COVID, post-acute sequelae of SARS-CoV-2, rehabilitation, cardiovascular complications, neurocognitive symptoms. |
| Field | Medical / Pharmacy |
| Published In | Volume 17, Issue 2, April-June 2026 |
| Published On | 2026-06-06 |
| DOI | https://doi.org/10.71097/IJSAT.v17.i2.11249 |
Share this

CrossRef DOI is assigned to each research paper published in our journal.
IJSAT DOI prefix is
10.71097/IJSAT
Downloads
All research papers published on this website are licensed under Creative Commons Attribution-ShareAlike 4.0 International License, and all rights belong to their respective authors/researchers.